ATXN3L and hepatocellular carcinoma: Interestingly, we analyzed that the prognostic value of MJDs family members’ expression levels in HCC patients revealed that higher mRNA expression of AXTN3 and ATXN3L have better OS, DSS, PFS, and RFS, which was not consistent with previous studies.